Search

More large companies opening on-site clinics for employees

MORE LARGE COMPANIES OPENING ON-SITE CLINICS FOR EMPLOYEES

According to a 2017 employer survey, a third of companies with more than 5,000 employees now offer general medical clinics at their...

 
 
 
Risk Factors for the Development of Postoperative Delirium in Pediatric Intensive Care Patients

RISK FACTORS FOR THE DEVELOPMENT OF POSTOPERATIVE DELIRIUM IN PEDIATRIC INTENSIVE CARE PATIENTS

Objectives: To determine and quantify risk factors for postoperative pediatric delirium. Design: Single-center prospective cohort study. Setting: Twenty-two...

Bi-Modal Arterial Compliance Probe for Calibration-Free Cuffless Blood Pressure Estimation

BI-MODAL ARTERIAL COMPLIANCE PROBE FOR CALIBRATION-FREE CUFFLESS BLOOD PRESSURE ESTIMATION

Non-invasive measurement of Blood Pressure has well-established utility in screening, clinical diagnosis and patient follow-up for...

 
 
 

GLAXOSMITHKLINE'S RHEUMATOID ARTHRITIS PROSPECT MISSES PHASE 2 ENDPOINT

GlaxoSmithKline has missed the primary endpoint in a phase 2 trial of rheumatoid arthritis prospect GSK3196165. The highest dose of...

ESMO18: MERCK'S STING AGONIST LACKS BITE ON ITS OWN

Amid high expectations, the first clinical data with Merck & Co's STING agonist at ESMO has proved a disappointment-at least as a monotherapy.

 
 
 

MIRATI THERAPEUTICS PRESENTS UPDATED POSITIVE CLINICAL DATA FROM SITRAVATINIB IMMUNO-ONCOLOGY COMBINATION TRIAL AT ESMO 2018 CONGRESS AND ANNOUNCES FDA GUIDANCE FOR REGISTRATION TRIAL

Updated analysis from ongoing Phase 2 trial of sitravatinib in combination with nivolumab demonstrated significant clinical activity...

 
 
 

SEEKING PAID VOLUNTEERS FOR A 1.5 HOUR CLINIC VISIT: TUE OCT 23

Are you interested in participating in a clinical research study to help prevent deep vein thrombosis ? We are looking for healthy...

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

 
 
 
BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

BIO INVESTOR FORUM EXPLORES “DIGICEUTICALS” AS A NEW CLASS OF FDA-APPROVED THERAPEUTICS

Within the past year, the FDA has launched a provider pre-certification program as a pilot to manage the expansion of “digiceuticals”...

Breast cancer vaccine now in clinical trials could someday save millions

BREAST CANCER VACCINE NOW IN CLINICAL TRIALS COULD SOMEDAY SAVE MILLIONS

Doctors said that although the vaccine is still in clinical trials, early results indicate that it seems to be working with few negative...

 
 
 
Warp Drive's Odyssey Ends with a Buyout-By Revolution, Not Sanofi

WARP DRIVE'S ODYSSEY ENDS WITH A BUYOUT-BY REVOLUTION, NOT SANOFI

Warp Drive Bio started up in 2012 with a potential buyer, Sanofi, already in place. Six years later the Cambridge, MA, company is being...

Study: Reflexion Health Virtual Therapy System Reduces Rehab Costs

STUDY: REFLEXION HEALTH VIRTUAL THERAPY SYSTEM REDUCES REHAB COSTS

Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a...

 
 
 
Apple Watch used for major clinical study of knee and joint replacement patients

APPLE WATCH USED FOR MAJOR CLINICAL STUDY OF KNEE AND JOINT REPLACEMENT PATIENTS

Apple Watch is thriving as an approachable health tracking solution, especially for heart-related issues thanks to heart rate alerts...

Apple Teams Up With Zimmer Biomet for Clinical Study on Joint Replacement

APPLE TEAMS UP WITH ZIMMER BIOMET FOR CLINICAL STUDY ON JOINT REPLACEMENT

Zimmer Biomet, a company that develops joint replacement products, today announced that it is working with Apple to improve patient...

 
 
 
Alnylam Won't Seek Quick FDA Nod For Second RNAi Drug

ALNYLAM WON'T SEEK QUICK FDA NOD FOR SECOND RNAI DRUG

A few weeks ago, Alnylam Pharmaceuticals indicated it might seek a speedy FDA approval for what could be the second-ever RNA interference...

True Story: I Got Botox to Help Fix My Posture

TRUE STORY: I GOT BOTOX TO HELP FIX MY POSTURE

About an hour before my first-ever Botox consultation at GoodSkin , the L.A. anti-aging clinic known for its "untouched" approach to...

 
 
 

SENIOR SCIENTIST, ANALYTICAL DEVELOPMENT - F1 ONCOLOGY - SAN DIEGO, CA

F1 Oncology is a clinical-stage biotechnology company committed to bringing to market CAR-T therapies for the treatment of cancer...From...

FDA LIFTS CLINICAL HOLD; GREEN-LIGHTS VERTEX AND CRISPR'S SICKLE CELL GENE THERAPY TRIAL

Posted on: 14 October 2018, The U.S. Food and Drug Administration has lifted a clinical hold and accepted an Investigational New Drug...